000999SZSE

Announcement on Guarantee Plan for Kunming Pharmaceutical Group in 2026

✨ AI Summary

China Resources Sanjiu Pharmaceutical Co., Ltd. announced a guarantee plan for its controlling subsidiary, Kunming Pharmaceutical Group, for 2026. The plan includes joint liability guarantees for bank financing credit not exceeding RMB 116.9 million, representing 2.18% of Kunming Pharmaceutical Group's net assets. The board approved the proposal with unanimous support, pending shareholder review. The guarantees will support various subsidiaries, with specific amounts allocated based on their debt-to-asset ratios.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· OpenAI

Stock Code: 000999 Stock Abbreviation: China Resources Sanjiu Announcement No.: 2026—011
China Resources Sanjiu Pharmaceutical Co., Ltd.
Announcement on the Guarantee Plan for the Year 2026 of the Company's Controlling Subsidiary Kunming Pharmaceutical Group

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate, and complete, without any false records, misleading statements, or significant omissions.

I. Overview of the Guarantee Situation of the Controlling Subsidiary
In 2026, to meet the business development needs of the company's controlling subsidiary Kunming Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Kunming Pharmaceutical Group") and its related subsidiaries, and to satisfy the financing guarantee requirements of the relevant companies, Kunming Pharmaceutical Group and its subsidiaries are expected to provide joint liability guarantees for bank financing credit business not exceeding RMB 116.9 million, accounting for 2.18% of Kunming Pharmaceutical Group's most recent audited net assets and 0.53% of China Resources Sanjiu's most recent audited net assets. Among them, for subsidiaries with a debt-to-asset ratio exceeding 70%, joint liability guarantees for bank financing credit business not exceeding RMB 76.2 million will be provided, accounting for 1.42% of Kunming Pharmaceutical Group's most recent audited net assets and 0.34% of China Resources Sanjiu's most recent audited net assets; for subsidiaries with a debt-to-asset ratio not exceeding 70%, joint liability guarantees for bank financing credit business not exceeding RMB 40.7 million will be provided, accounting for 0.76% of Kunming Pharmaceutical Group's most recent audited net assets and 0.18% of China Resources Sanjiu's most recent audited net assets. Among them, the guarantee plan amount for Kunming Pharmaceutical Group's headquarters in 2026 is RMB 55 million, involving 2 guaranteed units; the guarantee plan amount for Kunming Pharmaceutical Commercial Co., Ltd. (hereinafter referred to as "Kunming Commercial") in 2026 is RMB 61.9 million, involving 5 guaranteed units.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.